Lv22
150 积分 2025-04-18 加入
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
55分钟前
求助中
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
1小时前
已关闭
[Exploring the clinical genetic characteristics and height for age growth curve of 210 patients with achondroplasia in China]
8天前
已完结
软骨发育不全治疗的研究进展综述
1个月前
已完结
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
3个月前
已完结
Post-Progression treatment options after CDK4/6 inhibitors in hormone Receptor-Positive HER2-Negative metastatic breast cancer
5个月前
已完结
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
6个月前
已完结
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
6个月前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
6个月前
已完结
Heterogeneity and treatment landscape of ovarian carcinoma
6个月前
已完结
皖公网安备34019202002308
